Form 4: Life360 Director Sells Shares After Option Exercise

Life360 Director Charles J. Prober exercised options and sold 7,930 shares of common stock on January 13, 2026, under a pre-arranged 10b5-1 trading plan.

Summary

• Charles J. Prober, a Director of Life360, Inc. (LIF), reported transactions on January 13, 2026.
• Mr. Prober exercised options to acquire 7,930 shares of common stock at an exercise price of $11.18 per share.
• Simultaneously, he sold 7,930 shares of common stock at a price of $61.98 per share.
• These transactions were executed pursuant to a Rule 10b5-1 trading plan adopted on March 14, 2025.
• Following these transactions, Mr. Prober beneficially owns 105,456 shares of common stock, which includes 1,357 restricted stock units.
• Mr. Prober also holds stock options for 79,300 shares of common stock with an exercise price of $11.18, which vest according to a schedule starting April 1, 2024.

Sentiment

Score: 6

Explanation: The transactions were executed under a pre-established 10b5-1 plan, indicating a routine and planned event rather than a reaction to new information. The sale at a significantly higher price than the exercise price is a positive for the insider, though insider selling can be viewed neutrally by the market.

Positives

• The transactions were conducted under a pre-established Rule 10b5-1 trading plan, indicating a planned and transparent sale not based on immediate material nonpublic information.
• The sale price of $61.98 per share is significantly higher than the exercise price of $11.18, indicating a profitable transaction for the insider.

Negatives

• An insider sale, even if planned, can sometimes be perceived negatively by the market, suggesting a lack of confidence, though this is mitigated by the 10b5-1 plan.

Future Outlook

The remaining stock options will continue to vest in equal monthly installments after April 1, 2024, until fully vested, subject to the reporting person's continuing service.

Industry Context

This filing reports a routine insider transaction by a director, which is a common occurrence in publicly traded companies and does not inherently reflect broader industry trends.

Stakeholder Impact

• Shareholders: Minor impact. Routine insider sales under a 10b5-1 plan are generally not highly price-sensitive but represent an insider taking profits.

Next Steps

• The remaining stock options will continue to vest in equal monthly installments after April 1, 2024, until fully vested, subject to the reporting person's continuing service.

Key Dates

Recommendation

This Form 4 reports a routine, pre-planned insider transaction (exercise of options and sale of shares) by a director. While it represents an insider taking profits, the execution under a 10b5-1 plan mitigates concerns about trading on non-public information. This filing alone does not provide sufficient new information to warrant a change in investment thesis, thus a 'hold' recommendation is appropriate.

Keywords

Life360, LIF, Form 4, insider trading, stock option exercise, share sale, Rule 10b5-1, director, beneficial ownership